A discovery made five years ago by scientists at MDI Biological Laboratory (MDIBL) is causing quite a lot of excitement. It’s a molecule with the scintillating name of MSI-1436 that has been shown to stimulate the repair and regeneration of heart muscle in mice after a heart attack. Following that breakthrough, MDIBL President Kevin Strange and his research colleague Voot Yin created a company called Novo Biosciences to explore the molecule’s potential to have the same effect in other mammals and ultimately in humans. “People have been looking for drugs to do what ours does for 45 years,” Strange said. “We don’t know if it will work in humans, but if it does it will change the world. It will change the way we treat a heart attack. Read More
MDI Bio Lab spawning business ventures
Related Posts
Maine’s startup ‘mojo’ highlighted in national ranking
As a place to start a business, Maine’s “mojo” is going strong, as shown in a new national ranking released Tuesday by WalletHub,...
Maine CDC Director Nirav Shah to join U.S. CDC leadership
Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention, has been appointed principal deputy director at the...
$5.6M in state funding to support Maine startups, entrepreneurs
Sixteen Maine organizations helping startups and entrepreneurs will share $5.6 million in state funding from the Pandemic Recovery for an Innovative Maine...